Channel Info


Joined February, 29, 2008
Acomplia Rimonabant , discovered and developed by French pharmaceutical company Sanofi-Synthelabo, is a new drug thas has shown great promise in trials for the treatment of obesity and related metabolic risk factors. Rimonabant is already on the market in Europe, being sold under the trade name Acomplia , and is awaiting approval in the United States. If you want to get Acomplia in United States you will get the package under the generic name Rimonabant.
United States